Global TDS(Transdermal Delivery Systems) Market By Product Type (Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive) And By End-Users/Application (Hospital, Clinic) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-982830
  • April 2021
  • Pharmaceuticals
  • 118 Pages

Report Preview

The TDS(Transdermal Delivery Systems) Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)

The TDS(Transdermal Delivery Systems) Market has been valued at US$ xx Mn in the year 2020 and is anticipated to attain US$ xx Mn by the year 2028 along with a CAGR of xx%

TDS(Transdermal Delivery Systems) Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the TDS(Transdermal Delivery Systems) market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Others
Applications Hospital, Clinic, Other
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Adhex Pharma, Harro Hofliger, Tesa Labtec, Toyochem, Teva Pharmaceutical, Pfizer, IBSA Group, Teikoku Seiyaku, Endo International, Hisamitsu, Mylan, Sorrento Therapeutics
 
TDS(Transdermal Delivery Systems) Market Competitive and Premeditated Analysis
In the TDS(Transdermal Delivery Systems) report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the TDS(Transdermal Delivery Systems) research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
TDS(Transdermal Delivery Systems) Market Segmentation Analysis:
The TDS(Transdermal Delivery Systems) market is segmented into various sections such as product types, applications as well as end users and regions. Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

Segmentation based on type includes Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Others   

The application segment includes   Hospital, Clinic, Other

Major Key Players for Global TDS(Transdermal Delivery Systems) Market:
The TDS(Transdermal Delivery Systems) market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Adhex Pharma, Harro Hofliger, Tesa Labtec, Toyochem, Teva Pharmaceutical, Pfizer, IBSA Group, Teikoku Seiyaku, Endo International, Hisamitsu, Mylan, Sorrento Therapeutics
 
The TDS(Transdermal Delivery Systems) market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Regional Analysis of the TDS(Transdermal Delivery Systems) market:
The TDS(Transdermal Delivery Systems) market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

The Global segmentation of the TDS(Transdermal Delivery Systems) market:
By Type:
  • Single-layer Drug-in-Adhesive
  • Multi-layer Drug-in-Adhesive
  • Others

By Application
  • Hospital
  • Clinic
  • Other

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


 
Major Factors Included and highlighted in the TDS(Transdermal Delivery Systems) report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire TDS(Transdermal Delivery Systems) market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the TDS(Transdermal Delivery Systems) market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the TDS(Transdermal Delivery Systems) market is included in the report.
 
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the TDS(Transdermal Delivery Systems) market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the TDS(Transdermal Delivery Systems) market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the TDS(Transdermal Delivery Systems) market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the TDS(Transdermal Delivery Systems) market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the TDS(Transdermal Delivery Systems) market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global TDS(Transdermal Delivery Systems) Market Snapshot
          2.1.1. Global TDS(Transdermal Delivery Systems) Market By Type,2019
               2.1.1.1.Single-layer Drug-in-Adhesive
               2.1.1.2.Multi-layer Drug-in-Adhesive
               2.1.1.3.Others
          2.1.2. Global TDS(Transdermal Delivery Systems) Market By Application,2019
               2.1.2.1.Hospital
               2.1.2.2.Clinic
               2.1.2.3.Other
          2.1.3. Global TDS(Transdermal Delivery Systems) Market By End-use,2019
          2.1.4. Global TDS(Transdermal Delivery Systems) Market By Geography,2019

3. Global TDS(Transdermal Delivery Systems) Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global TDS(Transdermal Delivery Systems) Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global TDS(Transdermal Delivery Systems) Market Size (US$), By Type, 2018 – 2028

5. Global TDS(Transdermal Delivery Systems) Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global TDS(Transdermal Delivery Systems) Market Size (US$), By Application, 2018 – 2028

6. Global TDS(Transdermal Delivery Systems) Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global TDS(Transdermal Delivery Systems) Market Size (US$), By End-use, 2018 – 2028

7. Global TDS(Transdermal Delivery Systems) Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America TDS(Transdermal Delivery Systems) Market Analysis, 2018 – 2028 
          7.2.1. North America TDS(Transdermal Delivery Systems) Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America TDS(Transdermal Delivery Systems) Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America TDS(Transdermal Delivery Systems) Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America TDS(Transdermal Delivery Systems) Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe TDS(Transdermal Delivery Systems) Market Analysis, 2018 – 2028 
          7.3.1.  Europe TDS(Transdermal Delivery Systems) Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe TDS(Transdermal Delivery Systems) Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe TDS(Transdermal Delivery Systems) Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe TDS(Transdermal Delivery Systems) Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific TDS(Transdermal Delivery Systems) Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific TDS(Transdermal Delivery Systems) Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific TDS(Transdermal Delivery Systems) Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific TDS(Transdermal Delivery Systems) Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific TDS(Transdermal Delivery Systems) Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America TDS(Transdermal Delivery Systems) Market Analysis, 2018 – 2028 
          7.5.1.  Latin America TDS(Transdermal Delivery Systems) Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America TDS(Transdermal Delivery Systems) Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America TDS(Transdermal Delivery Systems) Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America TDS(Transdermal Delivery Systems) Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) TDS(Transdermal Delivery Systems) Market Analysis, 2018 – 2028 
          7.6.1.  MEA TDS(Transdermal Delivery Systems) Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA TDS(Transdermal Delivery Systems) Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA TDS(Transdermal Delivery Systems) Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA TDS(Transdermal Delivery Systems) Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key TDS(Transdermal Delivery Systems) Providers
        8.4.1 Adhex Pharma
                8.1.1 Business Description
                8.1.2 Adhex Pharma Geographic Operations
                8.1.3 Adhex Pharma Financial Information
                8.1.4 Adhex Pharma Product Positions/Portfolio
                8.1.5 Adhex Pharma Key Developments
        8.4.2 Harro Hofliger
                8.2.1 Business Description
                8.2.2 Harro Hofliger Geographic Operations
                8.2.3 Harro Hofliger Financial Information
                8.2.4 Harro Hofliger Product Positions/Portfolio
                8.2.5 Harro Hofliger Key Developments
        8.4.3 Tesa Labtec
                8.3.1 Business Description
                8.3.2 Tesa Labtec Geographic Operations
                8.3.3 Tesa Labtec Financial Information
                8.3.4 Tesa Labtec Product Positions/Portfolio
                8.3.5 Tesa Labtec Key Developments
        8.4.4 Toyochem
                8.4.1 Business Description
                8.4.2 Toyochem Geographic Operations
                8.4.3 Toyochem Financial Information
                8.4.4 Toyochem Product Positions/Portfolio
                8.4.5 Toyochem Key Developments
        8.4.5 Teva Pharmaceutical
                8.5.1 Business Description
                8.5.2 Teva Pharmaceutical Geographic Operations
                8.5.3 Teva Pharmaceutical Financial Information
                8.5.4 Teva Pharmaceutical Product Positions/Portfolio
                8.5.5 Teva Pharmaceutical Key Developments
        8.4.6 Pfizer
                8.6.1 Business Description
                8.6.2 Pfizer Geographic Operations
                8.6.3 Pfizer Financial Information
                8.6.4 Pfizer Product Positions/Portfolio
                8.6.5 Pfizer Key Developments
        8.4.7 IBSA Group
                8.7.1 Business Description
                8.7.2 IBSA Group Geographic Operations
                8.7.3 IBSA Group Financial Information
                8.7.4 IBSA Group Product Positions/Portfolio
                8.7.5 IBSA Group Key Developments
        8.4.8 Teikoku Seiyaku
                8.8.1 Business Description
                8.8.2 Teikoku Seiyaku Geographic Operations
                8.8.3 Teikoku Seiyaku Financial Information
                8.8.4 Teikoku Seiyaku Product Positions/Portfolio
                8.8.5 Teikoku Seiyaku Key Developments
        8.4.9 Endo International
                8.9.1 Business Description
                8.9.2 Endo International Geographic Operations
                8.9.3 Endo International Financial Information
                8.9.4 Endo International Product Positions/Portfolio
                8.9.5 Endo International Key Developments
        8.4.10 Hisamitsu
                8.10.1 Business Description
                8.10.2 Hisamitsu Geographic Operations
                8.10.3 Hisamitsu Financial Information
                8.10.4 Hisamitsu Product Positions/Portfolio
                8.10.5 Hisamitsu Key Developments
        8.4.11 Mylan
                8.11.1 Business Description
                8.11.2 Mylan Geographic Operations
                8.11.3 Mylan Financial Information
                8.11.4 Mylan Product Positions/Portfolio
                8.11.5 Mylan Key Developments
        8.4.12 Sorrento Therapeutics
                8.12.1 Business Description
                8.12.2 Sorrento Therapeutics Geographic Operations
                8.12.3 Sorrento Therapeutics Financial Information
                8.12.4 Sorrento Therapeutics Product Positions/Portfolio
                8.12.5 Sorrento Therapeutics Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global TDS(Transdermal Delivery Systems) Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America TDS(Transdermal Delivery Systems) Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America TDS(Transdermal Delivery Systems) Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America TDS(Transdermal Delivery Systems) Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe TDS(Transdermal Delivery Systems) Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe TDS(Transdermal Delivery Systems) Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe TDS(Transdermal Delivery Systems) Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific TDS(Transdermal Delivery Systems) Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific TDS(Transdermal Delivery Systems) Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific TDS(Transdermal Delivery Systems) Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America TDS(Transdermal Delivery Systems) Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America TDS(Transdermal Delivery Systems) Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America TDS(Transdermal Delivery Systems) Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA TDS(Transdermal Delivery Systems) Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA TDS(Transdermal Delivery Systems) Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA TDS(Transdermal Delivery Systems) Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global TDS(Transdermal Delivery Systems): Market Segmentation 
FIG. 2 Global TDS(Transdermal Delivery Systems) Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global TDS(Transdermal Delivery Systems) Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global TDS(Transdermal Delivery Systems) Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global TDS(Transdermal Delivery Systems) Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global TDS(Transdermal Delivery Systems) Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global TDS(Transdermal Delivery Systems) Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key TDS(Transdermal Delivery Systems) Providers, 2019
FIG. 11 Global TDS(Transdermal Delivery Systems) Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global TDS(Transdermal Delivery Systems) Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global TDS(Transdermal Delivery Systems) Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America TDS(Transdermal Delivery Systems) Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe TDS(Transdermal Delivery Systems) Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific TDS(Transdermal Delivery Systems) Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America TDS(Transdermal Delivery Systems) Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA TDS(Transdermal Delivery Systems) Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the TDS(Transdermal Delivery Systems) market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global TDS(Transdermal Delivery Systems) Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America TDS(Transdermal Delivery Systems) Market Value, By Segment1, 2018 – 2028
TABLE  North America TDS(Transdermal Delivery Systems) Market Value, By Segment2, 2018 – 2028
TABLE  North America TDS(Transdermal Delivery Systems) Market Value, By Country, 2018 – 2028
TABLE  Europe TDS(Transdermal Delivery Systems) Market Value, By Segment1, 2018 – 2028
TABLE  Europe TDS(Transdermal Delivery Systems) Market Value, By Segment2, 2018 – 2028
TABLE  Europe TDS(Transdermal Delivery Systems) Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific TDS(Transdermal Delivery Systems) Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific TDS(Transdermal Delivery Systems) Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific TDS(Transdermal Delivery Systems) Market Value, By Country, 2018 – 2028
TABLE  Latin America TDS(Transdermal Delivery Systems) Market Value, By Segment1, 2018 – 2028
TABLE  Latin America TDS(Transdermal Delivery Systems) Market Value, By Segment2, 2018 – 2028
TABLE  Latin America TDS(Transdermal Delivery Systems) Market Value, By Country, 2018 – 2028
TABLE  MEA TDS(Transdermal Delivery Systems) Market Value, By Segment1, 2018 – 2028
TABLE  MEA TDS(Transdermal Delivery Systems) Market Value, By Segment2, 2018 – 2028
TABLE  MEA TDS(Transdermal Delivery Systems) Market Value, By Country, 2018 – 2028
TABLE  Adhex Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Harro Hofliger: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Tesa Labtec: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Toyochem: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teva Pharmaceutical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  IBSA Group: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teikoku Seiyaku: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Endo International: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hisamitsu: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mylan: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sorrento Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global TDS(Transdermal Delivery Systems) Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global TDS(Transdermal Delivery Systems) Market, By Segment1, 2019 (US$ Mn)
FIG.  Global TDS(Transdermal Delivery Systems) Market, By Segment2, 2019 (US$ Mn)
FIG.  Global TDS(Transdermal Delivery Systems) Market, By Geography, 2019 (US$ Mn)
FIG.  Global TDS(Transdermal Delivery Systems) Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key TDS(Transdermal Delivery Systems) Providers, 2016
FIG.  Global TDS(Transdermal Delivery Systems) Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Single-layer Drug-in-Adhesive Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Multi-layer Drug-in-Adhesive Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global TDS(Transdermal Delivery Systems) Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Hospital Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Clinic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Other Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. TDS(Transdermal Delivery Systems) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada TDS(Transdermal Delivery Systems) Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK TDS(Transdermal Delivery Systems) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany TDS(Transdermal Delivery Systems) Market Value, 2018 – 2028, (US$ Mn)
FIG.  France TDS(Transdermal Delivery Systems) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe TDS(Transdermal Delivery Systems) Market Value, 2018 – 2028, (US$ Mn)
FIG.  China TDS(Transdermal Delivery Systems) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan TDS(Transdermal Delivery Systems) Market Value, 2018 – 2028, (US$ Mn)
FIG.  India TDS(Transdermal Delivery Systems) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific TDS(Transdermal Delivery Systems) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico TDS(Transdermal Delivery Systems) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil TDS(Transdermal Delivery Systems) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America TDS(Transdermal Delivery Systems) Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries TDS(Transdermal Delivery Systems) Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa TDS(Transdermal Delivery Systems) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA TDS(Transdermal Delivery Systems) Market Value, 2018 – 2028, (US$ Mn)